Philippe Horvath

Senior Lead Scientist, Technical Fellow, IFF Health & Biosciences

Philippe Horvath is a Senior Lead Scientist and Technical Fellow at IFF Health & Biosciences. He graduated from Université Louis-Pasteur in Strasbourg, France in 1996 and earned his Ph.D. in Cellular and Molecular Biology in 2000. Philippe joined Rhodia Food’s R&D center in Dangé-Saint-Romain in 2000 and has continued through the company’s evolution from Rhodia to Danisco, DuPont, and now IFF.

Since 2002, much of his research has focused on CRISPR technology, first as a tool for strain differentiation and tracking, and later as a bacterial immune system with broad industrial, biotechnological, and medical applications. Philippe is widely recognized as one of the pioneers in CRISPR research and innovation.

Follow Me:

Notable Achievements

Recipient of the 2008 Danisco Innovation Award
Recipient of the 2013 Bolton/Carothers Innovative Science Award
Recipient of the 2015 Massry Prize
Recipient of the 2016 Warren Alpert Foundation Prize
Recipient of the 2016 Canada Gairdner International Award
Recipient of the 2018 Bower Award and Prize for Achievement in Science
Named a Highly Cited Researcher by Thomson Reuters/Clarivate Analytics from 2015–2021
Inducted into the National Inventors Hall of Fame in 2023
Co-inventor on approximately 25 patent families, including 8 related to CRISPR technologies
Co-author of more than 50 peer-reviewed scientific publications and 4 book chapters

Research Impact & Scientific Leadership

Research Focus Philippe’s recent publication contributes to the ongoing classification and understanding of natural CRISPR-Cas systems. This work updates foundational CRISPR knowledge used extensively by researchers across biotechnology, microbiology, and life sciences.

Trade Associations, Awards & Recognition See notable achievements above. Philippe’s scientific contributions have been recognized globally through prestigious awards and industry recognition, reflecting his impact on the development and understanding of CRISPR technology.